These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 29869584)
1. Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system. Strickland JC; Staton M; Leukefeld CG; Oser CB; Webster JM Int J Prison Health; 2018 Jun; 14(2):89-100. PubMed ID: 29869584 [TBL] [Abstract][Full Text] [Related]
2. "Seek, test, treat and retain" for hepatitis C in the United States criminal justice system. Larney S; G Beckwith C; D Zaller N; T Montague B; Rich J Int J Prison Health; 2014; 10(3):164-71. PubMed ID: 25764176 [TBL] [Abstract][Full Text] [Related]
3. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California. Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic. Hoff E; Warden A; Taylor R; Nijhawan AE Public Health Rep; 2023; 138(2):248-258. PubMed ID: 35238249 [TBL] [Abstract][Full Text] [Related]
5. Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women. Staton-Tindall M; Webster JM; Oser CB; Havens JR; Leukefeld CG Soc Work Public Health; 2015; 30(4):385-96. PubMed ID: 25950907 [TBL] [Abstract][Full Text] [Related]
6. Gender-specific participation and outcomes among jail diversion clients with co-occurring substance use and mental health disorders. Robertson AG; Easter MM; Lin HJ; Khoury D; Pierce J; Swanson J; Swartz M J Subst Abuse Treat; 2020 Aug; 115():108035. PubMed ID: 32600621 [TBL] [Abstract][Full Text] [Related]
7. The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review. Seval N; Wurcel A; Gunderson CG; Grimshaw A; Springer SA Infect Dis Clin North Am; 2020 Sep; 34(3):559-584. PubMed ID: 32782102 [TBL] [Abstract][Full Text] [Related]
8. An exploratory study of mental health and HIV risk behavior among drug-using rural women in jail. Staton-Tindall M; Harp KLH; Minieri A; Oser C; Webster JM; Havens J; Leukefeld C Psychiatr Rehabil J; 2015 Mar; 38(1):45-54. PubMed ID: 25799305 [TBL] [Abstract][Full Text] [Related]
9. HIV and HCV in U.S. Prisons and Jails: The Correctional Facility as a Bellwether Over Time for the Community's Infections. Spaulding AC; Anderson EJ; Khan MA; Taborda-Vidarte CA; Phillips JA AIDS Rev; 2017; 19(3):134-147. PubMed ID: 28926560 [TBL] [Abstract][Full Text] [Related]
10. Drug Use and Incarceration among Rural Appalachian Women: Findings From a Jail Sample. Staton M; Ciciurkaite G; Oser C; Tillson M; Leukefeld C; Webster JM; Havens JR Subst Use Misuse; 2018 May; 53(6):931-941. PubMed ID: 29161158 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650 [TBL] [Abstract][Full Text] [Related]
12. Breaking the addictive cycle of the system: improving US criminal justice practices to address substance use disorders. Kopak AM Int J Prison Health; 2015; 11(1):4-16. PubMed ID: 25751703 [TBL] [Abstract][Full Text] [Related]
13. Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration. Monico LB; Gryczynski J; Lee JD; Dusek K; McDonald R; Malone M; Sharma A; Cheng A; DeVeaugh-Geiss A; Chilcoat H J Subst Abuse Treat; 2021 Apr; 123():108267. PubMed ID: 33612198 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C in Australian prisons: a national needs assessment. Mina MM; Herawati L; Butler T; Lloyd A Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988 [TBL] [Abstract][Full Text] [Related]
15. Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study. Akiyama MJ; Ross J; Rimawi F; Fox A; Jordan AO; Wiersema J; Litwin AH; Kaba F; MacDonald R PLoS One; 2020; 15(12):e0242623. PubMed ID: 33264311 [TBL] [Abstract][Full Text] [Related]
16. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination. Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259 [TBL] [Abstract][Full Text] [Related]
17. Forensic assertive community treatment: preventing incarceration of adults with severe mental illness. Lamberti JS; Weisman R; Faden DI Psychiatr Serv; 2004 Nov; 55(11):1285-93. PubMed ID: 15534018 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India. Singh S; Prasad R; Mohanty A Int J STD AIDS; 1999 Jul; 10(7):475-8. PubMed ID: 10454185 [TBL] [Abstract][Full Text] [Related]
19. Assessment of hepatitis C risk factors and infection prevalence in a jail population. Wenger PJ; Rottnek F; Parker T; Crippin JS Am J Public Health; 2014 Sep; 104(9):1722-7. PubMed ID: 25033142 [TBL] [Abstract][Full Text] [Related]
20. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health. Morris MD; Brown B; Allen SA Int J Prison Health; 2017 Sep; 13(3-4):192-199. PubMed ID: 28914118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]